NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prostate Cancer Research

Prostate Cancer Research

Overview

Prostate Cancer Research is a UK-based charity founded in 1989 that funds medical research and invests in early-stage companies to develop new treatments and diagnostics for prostate cancer.

Year Founded

1989

Portfolio Companies

2

Investments

Prostate Cancer Research investments
CompanyDateStageLead
NanoveryApr 2023SeedCo-investor
Lucida MedicalMar 2021SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded1989

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.